Compare AUBN & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUBN | COEP |
|---|---|---|
| Founded | 1907 | 2017 |
| Country | United States | United States |
| Employees | N/A | 6 |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.3M | 91.2M |
| IPO Year | 1996 | N/A |
| Metric | AUBN | COEP |
|---|---|---|
| Price | $25.25 | $16.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.6K | ★ 92.3K |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | ★ 13.66 | N/A |
| EPS | ★ 0.63 | N/A |
| Revenue | ★ $619,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $40.49 | ★ N/A |
| Revenue Growth | ★ 0.81 | N/A |
| 52 Week Low | $19.93 | $6.80 |
| 52 Week High | $29.00 | $21.41 |
| Indicator | AUBN | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 61.97 | 72.18 |
| Support Level | $24.74 | $13.77 |
| Resistance Level | $25.33 | $19.19 |
| Average True Range (ATR) | 0.41 | 1.15 |
| MACD | 0.16 | 0.47 |
| Stochastic Oscillator | 76.17 | 87.62 |
Auburn National Bancorp Inc operates as a bank holding company, which offers checking, savings, transaction deposit accounts and certificates of deposit, and is an active residential mortgage lender in its primary service area. The Bank's primary service area includes the cities of Auburn and Opelika, Alabama and nearby surrounding areas in East Alabama, predominantly in Lee County. The Bank also offers commercial, financial, agricultural, real estate construction and consumer loan products and other financial services. The Bank also provides automated teller machine (ATM) services in East Alabama and operates ATM machines. The Bank offers Visa Checkcards, which are debit cards. The Bank offers online banking, bill payment and other electronic banking services through its Internet website.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.